Philippe Jablonski,Henner Knust,Matthias Nettekoven,Angelique Patiny-Adam,Hasane Ratni,Claus Riemer
申请号：
US12856691
公开号：
US08394834B2
申请日:
2010.08.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to a compounds of formula Iwherein R1, R2, Ar1, Ar2, R′, R″, m, n, and o are defined in the specification or to a pharmaceutically active salt, racemic mixture, enantiomer, optical isomer or to tautomeric form thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinsons disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
